The therapeutic potential of microdosing psychedelics in depression
Microdosing psychedelics is the repeated use of small doses of, for example, lysergic acid diethylamide (LSD) and psilocybin, typically for a few weeks. Despite the popular and scientific attention in recent years, and claims by users that it has therapeutic value in affective disorders like depress...
Main Author: | Kim P.C. Kuypers |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-08-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/2045125320950567 |
Similar Items
-
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
by: Nadia R. P. W. Hutten, et al.
Published: (2019-09-01) -
Asking questions of psychedelic microdosing
by: Lindsay P Cameron
Published: (2021-03-01) -
Investigating the role microdosing psychedelics could have in the treatment of depression
by: Bäckström, August, et al.
Published: (2021) -
A systematic study of microdosing psychedelics.
by: Vince Polito, et al.
Published: (2019-01-01) -
Psychedelic microdosing benefits and challenges: an empirical codebook
by: Thomas Anderson, et al.
Published: (2019-07-01)